2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
The Pharma Letter20h
Vertex partners with Orna to advance next-gen gene therapies
Vertex Pharmaceuticals and Orna Therapeutics announce a $4 billion collaboration to develop in vivo gene editing therapies ...